| The Efficacy of Ibogaine in the Treatment of Addiction; an open label, single fixed dose pilot-study of the efficacy of ibogaine in opiod-dependent subjects | The Efficacy of Ibogaine in the Treatment of Addiction; an open label, single fixed dose pilot-study of the efficacy of ibogaine in opiod-dependent subjects - Ibogaine in opioid addiction | NL-OMON40645 |
| Study of the cardiac safety of Ibogaine accompanied by psychotherapy in the treatment of addiction to cocaine and crack. | Cocaine and crack Addiction Treatment with Ibogaine - CATI: Cocaine Addiction Treatment Ibogaine | RBR-9zpc27 |
| Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial | Tolerability and Efficacy of Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial | NCT03380728 |
| CYP2D6 and the pharmacokinetics of ibogaine | The role of CYP2D6 in the pharmacokinetics of ibogaine in healthy volunteers | ACTRN12613000324718 |
| Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification | Preliminar Efficacy and Safety of Ibogaine in the Treatment of Methadone | NCT04003948 |
| Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure | A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Sequelae of Repeated Blast Exposure | NCT04313712 |
| Trifecta Research Study | Trifecta Research Study: Examining Hormone Replacement Therapy, Magnetic e-Resonance Therapy, Ibogaine, and 5-MeO-DMT in the Treatment of Posttraumatic Stress Disorder and Traumatic Brain Injury-related Cognitive Symptoms | NCT06810765 |
